Fiera Capital Corp has taken a position in the
Boston Scientific Corporation, while other investment and asset management firms, such as Tredje AP fonden, King Luther Capital Management Corp, and M&G PLC have also increased their stake in the company. The value of Boston Scientific's stocks has fluctuated recently in response to various factors such as
analyst ratings,
target adjustments, and a cautious
2026 revenue forecast. Despite the stock's tumultuous period, firms like Vanguard Group Inc. and Machina Capital S.A.S. have been buying Boston Scientific Corporation shares. However, the performance of a crucial segment has unnerved investors leading to a fall in the share price. On the brighter side, recent earnings surpassed expectations, even though the
fourth-quarter guidance left investors disappointed. Boston Scientific announces the acquisition of
Penumbra Inc, which could be a potential game-changer. Further, despite the mixed share performance, Boston Scientific Corporation is expected to deliver solid and durable growth in the long term, provided the valuation on Boston Scientific's $14.5 billion Penumbra deal doesn't become too optimistic.
Boston Scientific Corp BSX News Analytics from Wed, 23 Jul 2025 07:00:00 GMT to Sat, 21 Feb 2026 13:58:56 GMT -
Rating 3
- Innovation 6
- Information 5
- Rumor -5
